Chapter 16 The Burden

Colorectal Cancer

More than 50% of colorectal cancer can be prevented by adopting healthy behaviors.

Colorectal cancer is the second leading cause of cancer death worldwide, with an estimated 1.9 million new cases and 900,000 deaths. Incidence rates range from <5 per 100,000 in Cape Verde, Sierra Leone, and India to >45 per 100,000 in Denmark and Norway (Map 16.1) and are strongly correlated with human development levels (Figure 16.1).

Colorectal cancer incidence rises with increasing levels of human development, driven by lifestyle and dietary patterns linked to economic growth.

Figure 16.1

Colorectal cancer incidence, age-standardized rate (world) per 100,000, by Human Development Index (HDI) and continent, 2022

Overall incidence rates are increasing in transitioning countries (Figure 16.2), coinciding with a rising prevalence of risk factors, such as consumption of red meat, processed meat, sedentary lifestyle, excess body fatness, smoking (in some countries), and alcohol intake. In contrast, rates have declined or stabilized in many high-income countries, such as the United States, United Kingdom, and New Zealand, because of changing patterns in risk factors (Figure 16.3), such as less smoking, and uptake of screening in recent decades. This progress, however, is confined to older adults in many countries, as colorectal cancer rates have been rising among adults aged <50 years in numerous high-income countries since around the mid-1990s (Figure 16.2).

The rising incidence of colorectal cancer among young adults in numerous countries is a bellwether for the future global disease burden across all adult age groups.

Figure 16.2

Trends in colorectal cancer incidence by age group, age-standardized rate (world) per 100,000, 1953-2017

Australia
Belarus
China
Ecuador
India
Norway
Thailand
The Netherlands
United Kingdom
United States

20-49 years

50+ years

Studies of colorectal cancer incidence rates by birth cohort demonstrated that the risk of developing colorectal cancer is increasingly elevated among successive generations born since the 1950s. The reasons remain undetermined but may include increases in excess body weight and changes in diet.

Figure 16.3

Colorectal cancer risk factors and relative risk

Factors That Increase Risk
Relative Risk
Heredity and medical history
At least 1 first-degree relative
2.2
At least 1 first-degree relative with diagnosis before age 50
3.6
At least 1 second-degree relative
1.7
Inflammatory bowel disease
1.7
Type 2 diabetes
Male
1.4
Female
1.2
Behavioral factors
Heavy alcohol consumption
(daily average >3 drinks)
1.3
Obesity (body mass index ≥ kg/m²)
1.3
Colon
Male
1.5
Female
1.1
Rectum
Male
1.3
Female
1.0
Red meat consumption (100 g/day)
1.1
Processed meat consumption
(50 g/day)
1.2
Smoking
Proximal colon
1.2
Distal colon
1.1
Rectum
1.3
Factors That Decrease Risk
Relative Risk
Behavioral factors
Physical activity
0.7
Dairy consumption
0.9

Footnote

The risk of disease in people with a particular “exposure” compared to people without the exposure. For dietary factors the highest versus lowest consumption is compared. A value greater than 1 indicates higher risk with exposure, whereas less than 1 is a protective effect.

Colorectal cancer screening is associated with reduced incidence and mortality (Figure 16.4). However, whether to implement organized screening programs is dependent on both the disease magnitude and whether there are sufficient resources to provide adequate diagnostic follow-up and treatment services. Screening reaches only a small fraction of the target population worldwide, and even in countries where it is available, socioeconomic and regional disparities remain in screening uptake. Primary prevention represents an opportunity to mitigate the escalating global burden of colorectal cancer, including interventions that support individuals to quit smoking, abstain or reduce alcohol consumption, engage in regular exercise, and maintain a healthy diet and body weight.

Figure 16.4

Colorectal cancer screening techniques for which there is sufficient evidence of a mortality reduction and a favorable benefit-to-harm ratio

Stool-based tests
  • Screening every 2 year with guaiac test without rehydration
  • Screening every 1 or 2 years with higher-sensitivity guaiac test (with rehydration)
  • Screening every 2 year with fecal immunochemical test (FIT) for stool-based testing
Endoscopic Techniques
  • Single screening with sigmoidoscopy
  • Single screening with colonoscopy

Sources

Text

  • Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. Apr 2017;66(4):683-691. doi:10.1136/gutjnl-2015-310912
  • Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. Oct 2015;64(10):1637-49. doi:10.1136/gutjnl-2014-309086
  • Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal Cancer Incidence Patterns in the United States, 1974-2013. J Natl Cancer Inst. Aug 1 2017;109(8)doi:10.1093/jnci/djw322
  • Chung RY, Tsoi KKF, Kyaw MH, Lui AR, Lai FTT, Sung JJ. A population-based age-period-cohort study of colorectal cancer incidence comparing Asia against the West. Cancer Epidemiol. Apr 2019;59:29-36. doi:10.1016/j.canep.2019.01.007
  • Larsen IK, Bray F. Trends in colorectal cancer incidence in Norway 1962-2006: an interpretation of the temporal patterns by anatomic subsite. Int J Cancer. Feb 1 2010;126(3):721-32. doi:10.1002/ijc.24839
  • Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. Dec 2019;68(12):2179-2185. doi:10.1136/gutjnl-2019-319511
  • O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Rates of colon and rectal cancers are increasing in young adults. Am Surg. Oct 2003;69(10):866-72.
  • Araghi M, Soerjomataram I, Bardot A, et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. The Lancet Gastroenterology & Hepatology. 2019;4(7):511-518. doi:10.1016/S2468-1253(19)30147-5
  • Vuik FE, Nieuwenburg SA, Bardou M, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut. Oct 2019;68(10):1820-1826. doi:10.1136/gutjnl-2018-317592
  • Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nature Reviews Gastroenterology & Hepatology. 2019/12/01 2019;16(12):713-732. doi:10.1038/s41575-019-0189-8
  • Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K. The IARC Perspective on Colorectal Cancer Screening. N Engl J Med. May 3 2018;378(18):1734-1740. doi:10.1056/NEJMsr1714643
  • Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol. Aug 2022;19(8):521-531. doi:10.1038/s41575-022-00612-y
  • Montalvan-Sanchez EE, Norwood DA, Dougherty M, et al. Colorectal Cancer Screening Programs in Latin America: A Systematic Review and Meta-Analysis. JAMA Network Open. 2024;7(2):e2354256-e2354256. doi:10.1001/jamanetworkopen.2023.54256
  • Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. The Lancet Oncology. 2021;22(7):1002-1013. doi:10.1016/S1470-2045(21)00199-6
  • Arnold M, Abnet CC, Neale RE, et al. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. Jul 2020;159(1):335-349.e15. doi:10.1053/j.gastro.2020.02.068

Maps

  • Map 16.1: Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer. https://gco.iarc.who.int/today.

Figures

  • Figure 16.1: Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer. https://gco.iarc.who.int/today.
  • Figure 16.2: Ervik M, Lam F, Laversanne M, Colombet M, Ferlay J, Miranda-Filho A, Bray F (2024). Global Cancer Observatory: Cancer Over Time. Lyon, France: International Agency for Research on Cancer. https://gco.iarc.who.int/overtime.
  • Figure 16.3: American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025. Atlanta: American Cancer Society; 2023
  • Figure 16.4: Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K. The IARC Perspective on Colorectal Cancer Screening. N Engl J Med. May 3 2018;378(18):1734-1740. doi:10.1056/NEJMsr1714643